Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial

Michael Koren, Leyi Lin, Kenneth H. Eckels, Rafael De La Barrera, Vincent Dussupt, Gina Donofrio, Erica L Sondergaard, Kristin T Mills, Merlin L. Robb, Christine Lee, O.S. Adedeji, Paul B. Keiser, Justin M Curley, Nathanial K. Copeland, Trevor A. Crowell, Jack Hutter, Melinda Hamer, Anais Valencia-Ruiz, Janice M. Darden, Sheila A. Peel, Mihret F. Amare, Tsedal Mebrahtu, Margaret C. Costanzo, Shelly J. Krebs, Gregory D. Gromowski, Richard G. Jarman, Stephen J. Thomas, Nelson L. Michael, Kayvon Modjarrad